These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
470 related articles for article (PubMed ID: 36438905)
1. A Necroptosis-Related Gene Signature to Predict the Prognosis of Skin Cutaneous Melanoma. Xie Y; Xu Z; Mei X; Shi W Dis Markers; 2022; 2022():8232024. PubMed ID: 36438905 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive Analysis of Necroptosis Landscape in Skin Cutaneous Melanoma for Appealing its Implications in Prognosis Estimation and Microenvironment Status. Cao X; He J; Chen A; Ran J; Li J; Chen D; Zhang H J Pers Med; 2023 Jan; 13(2):. PubMed ID: 36836481 [TBL] [Abstract][Full Text] [Related]
3. Analysis on tumor immune microenvironment and construction of a prognosis model for immune-related skin cutaneous melanoma. Wu M; Wang Z; Zhang J Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):671-681. PubMed ID: 37539569 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive prediction of immune microenvironment and hot and cold tumor differentiation in cutaneous melanoma based on necroptosis-related lncRNA. Zhang M; Yang L; Wang Y; Zuo Y; Chen D; Guo X Sci Rep; 2023 May; 13(1):7299. PubMed ID: 37147395 [TBL] [Abstract][Full Text] [Related]
5. Pan-cancer analysis of necroptosis-related gene signature for the identification of prognosis and immune significance. Ma J; Jin Y; Gong B; Li L; Zhao Q Discov Oncol; 2022 Mar; 13(1):17. PubMed ID: 35312867 [TBL] [Abstract][Full Text] [Related]
6. Integrative lactylation and tumor microenvironment signature as prognostic and therapeutic biomarkers in skin cutaneous melanoma. Zhu Y; Song B; Yang Z; Peng Y; Cui Z; Chen L; Song B J Cancer Res Clin Oncol; 2023 Dec; 149(20):17897-17919. PubMed ID: 37955686 [TBL] [Abstract][Full Text] [Related]
7. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma. Tian Q; Gao H; Zhao W; Zhou Y; Yang J Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650 [TBL] [Abstract][Full Text] [Related]
8. Identification of m6A-related lncRNAs-based signature for predicting the prognosis of patients with skin cutaneous melanoma. Lin W; Tan ZY; Fang XC SLAS Technol; 2024 Feb; 29(1):100101. PubMed ID: 37541541 [TBL] [Abstract][Full Text] [Related]
9. Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs. Liu D; Xu S; Chang T; Ma S; Wang K; Sun G; Chen S; Xu Y; Zhang H Front Immunol; 2022; 13():916800. PubMed ID: 35860239 [TBL] [Abstract][Full Text] [Related]
10. Construction of a Necroptosis-Associated Long Non-Coding RNA Signature to Predict Prognosis and Immune Response in Hepatocellular Carcinoma. Wang W; Ye Y; Zhang X; Ye X; Liu C; Bao L Front Mol Biosci; 2022; 9():937979. PubMed ID: 35911976 [No Abstract] [Full Text] [Related]
11. Ferroptosis-Related Gene Signature Predicts the Prognosis of Skin Cutaneous Melanoma and Response to Immunotherapy. Xu Z; Xie Y; Mao Y; Huang J; Mei X; Song J; Sun Y; Yao Z; Shi W Front Genet; 2021; 12():758981. PubMed ID: 34804126 [TBL] [Abstract][Full Text] [Related]
12. A Novel Necroptosis-Related Gene Signature in Skin Cutaneous Melanoma Prognosis and Tumor Microenvironment. Song B; Wu P; Liang Z; Wang J; Zheng Y; Wang Y; Chi H; Li Z; Song Y; Yin X; Yu Z; Song B Front Genet; 2022; 13():917007. PubMed ID: 35899194 [No Abstract] [Full Text] [Related]
13. Identification of novel disulfidptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of skin cutaneous melanoma patients. Cheng S; Wang X; Yang S; Liang J; Song C; Zhu Q; Chen W; Ren Z; Zhu F Skin Res Technol; 2024 Jul; 30(7):e13814. PubMed ID: 38924611 [TBL] [Abstract][Full Text] [Related]
14. The nucleosome remodeling and deacetylase complex has prognostic significance and associates with immune microenvironment in skin cutaneous melanoma. Liu X; Wang J Int Immunopharmacol; 2020 Nov; 88():106887. PubMed ID: 32799111 [TBL] [Abstract][Full Text] [Related]
15. Prognostic and immune-related value of STK17B in skin cutaneous melanoma. Shi X; Zhou Q; Huang B; Xia S; Jiang Y; Fang S; Lin J PLoS One; 2022; 17(2):e0263311. PubMed ID: 35171924 [TBL] [Abstract][Full Text] [Related]
16. The fatty acid-related gene signature stratifies poor prognosis patients and characterizes TIME in cutaneous melanoma. Hua S; Wang W; Yao Z; Gu J; Zhang H; Zhu J; Xie Z; Jiang H J Cancer Res Clin Oncol; 2024 Jan; 150(2):40. PubMed ID: 38279987 [TBL] [Abstract][Full Text] [Related]
17. Identification of a novel tumour microenvironment-based prognostic biomarker in skin cutaneous melanoma. Yang RH; Liang B; Li JH; Pi XB; Yu K; Xiang SJ; Gu N; Chen XD; Zhou ST J Cell Mol Med; 2021 Dec; 25(23):10990-11001. PubMed ID: 34755462 [TBL] [Abstract][Full Text] [Related]
18. A multi-omics-based investigation of the prognostic and immunological impact of necroptosis-related mRNA in patients with cervical squamous carcinoma and adenocarcinoma. Zou J; Lin Z; Jiao W; Chen J; Lin L; Zhang F; Zhang X; Zhao J Sci Rep; 2022 Oct; 12(1):16773. PubMed ID: 36202899 [TBL] [Abstract][Full Text] [Related]
19. System analysis based on the pyroptosis-related genes identifes GSDMD as a novel therapy target for skin cutaneous melanoma. Zhao S; Zhu Y; Liu H; He X; Xie J J Transl Med; 2023 Nov; 21(1):801. PubMed ID: 37950289 [TBL] [Abstract][Full Text] [Related]
20. Necroptosis-related LncRNAs in skin cutaneous melanoma: evaluating prognosis, predicting immunity, and guiding therapy. Liu J; Luo B; Zhang P; Jiang K; Hou Z; Cao X; Tang J BMC Cancer; 2023 Aug; 23(1):752. PubMed ID: 37580654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]